What is the recommended oral ferrous sulfate supplementation regimen for an elderly patient with confirmed iron‑deficiency anemia?

Ferrous Sulfate Supplementation in Geriatric Patients with Iron Deficiency Anemia

Start with one tablet of ferrous sulfate (200 mg, containing 65 mg elemental iron) once daily, taken in the morning on an empty stomach, and if not tolerated, switch to alternate-day dosing rather than increasing frequency. 1

Initial Dosing Regimen

• Begin with 50-100 mg elemental iron once daily (equivalent to one 200 mg ferrous sulfate tablet containing 65 mg elemental iron). 1
• Administer in the morning on an empty stomach to maximize absorption, as afternoon or evening dosing after a morning dose reduces iron uptake due to circadian hepcidin increases. 2
• Add vitamin C (ascorbic acid) to the iron supplement to enhance absorption. 3

Special Considerations for Elderly Patients

Iron deficiency in the elderly is often multifactorial, involving inadequate intake, malabsorption, chronic disease, and occult bleeding. 1 This complexity requires:

• Careful assessment of risks versus benefits of invasive investigations in patients with major comorbidities or limited performance status. 1
• Recognition that oral iron raises hemoglobin by only 0.35 g/dL after 4-6 weeks in elderly patients, though this is statistically significant. 4
• Do not defer iron replacement while awaiting diagnostic workup unless colonoscopy is imminent. 1

Managing Intolerance

If the patient cannot tolerate daily dosing:

• Switch to alternate-day dosing (one tablet every other day) rather than multiple daily doses. 1, 3
• Alternate-day dosing provides similar or superior iron absorption compared to daily dosing because oral iron doses ≥60 mg stimulate hepcidin elevation that persists 24 hours, blocking subsequent iron absorption. 2, 5
• Alternate-day regimens show significantly fewer gastrointestinal side effects (5.6% vs 13.9% moderate-to-severe events with daily dosing). 6, 7
• Recent evidence demonstrates that alternate-day dosing with 60 mg elemental iron produced greater hemoglobin increases (1.58 g/dL vs 0.41 g/dL at 21 days) compared to daily dosing in some studies. 5

Alternative Oral Formulations

If traditional ferrous salts are not tolerated even with alternate-day dosing:

• Consider ferric maltol (30 mg twice daily), which normalizes hemoglobin in 63-66% of patients with moderate IDA after 12 weeks, with gastrointestinal side effects comparable to placebo. 1
• Avoid switching between different ferrous salts (sulfate, fumarate, gluconate), as this practice is not supported by evidence. 1
• Modified-release preparations are less suitable for prescribing and offer no proven advantage. 1

Monitoring and Duration

• Check hemoglobin response within the first 4 weeks; expect at least a 10 g/L (1 g/dL) rise after 2 weeks of daily oral iron. 1
• Continue treatment for approximately 3 months after hemoglobin normalization to replenish bone marrow iron stores. 1
• Monitor blood counts every 6 months initially after treatment completion to detect recurrent IDA. 1

When to Use Parenteral Iron

Switch to intravenous iron if: 1, 3

• The patient does not tolerate oral iron despite alternate-day dosing
• Ferritin levels fail to improve after an adequate trial of oral iron
• Malabsorption is present (inflammatory bowel disease, celiac disease, post-bariatric surgery)
• Active inflammation compromises iron absorption
• Rapid correction is needed for symptomatic anemia

Prefer single or two-dose IV iron formulations over those requiring multiple infusions. 3

Common Pitfalls to Avoid

• Do not prescribe twice-daily or three-times-daily dosing as first-line therapy; this increases side effects without improving absorption due to hepcidin-mediated blockade. 2, 5, 7
• Do not use multiple daily doses to achieve faster response; if speed is critical, consider parenteral iron instead. 1
• Do not assume non-response means oral iron failure without checking compliance, ongoing blood loss, malabsorption, concurrent B12/folate deficiency, or chronic disease. 1
• Blood transfusion is rarely indicated for IDA; reserve for severe symptomatic anemia with circulatory compromise, and always follow with iron replacement as transfusion does not replenish iron stores. 1